Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
There is uncertainty about the site(s) of action of the antidiabetic thiazolidinediones (TZDs). These drugs are agonist ligands of the transcription factor PPARγ, which is abundant in adipose tissue but is normally present at very low levels in liver and muscle. We have studied the effects of TZDs i...
Gespeichert in:
| Veröffentlicht in: | J Clin Invest |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Clinical Investigation
2000
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC381440/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11086023/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI11245 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
